Newsletter | November 11, 2020

11.11.20 -- Flow Chemistry's Impact On Modern API Development/Manufacturing, And Other Insights

Six Principles For Getting Pharma Development Right From The Start
As the pharmaceutical industry faces pressure to bring new drugs to market more quickly and at minimal cost, pharmaceutical and biotechnology companies are increasingly outsourcing various parts of the drug development and manufacturing process. Here are six key points that pharmaceutical and biotechnology companies should keep in mind when looking to select the ideal partner to synthesize an API.
Avoid The Fallout From Incompatibility Between Your API And Its Formulation
It is critical the experts creating a drug product’s formulation are aware of any reactions that can occur between an API and a tablet’s excipients. This enables the correct choice of excipients, avoids unpleasant surprises at a later stage, and allows the focus to remain upon the manufacturing scale-up of both the drug substance and the formulated product.
Flow Chemistry: Scale-Up Solution For Modern API Manufacturing

Once deemed an “experts only” approach to chemical synthesis, flow chemistry is a cost-efficient technique growing in popularity that can facilitate scale-up, improve product quality, and even address some of pharma’s biggest challenges, such as drug shortages and recalls.